Sales & Marketing News | pharmaphorum

News

'Skinny' generic Vascepa label case reaches US Supreme Court

SCOTUS has agreed to hear a patent dispute between Amarin and Hikma that could have implications for 'skinny labels' used by generic manufacturers.

News

Wegovy pill shows strong early uptake, as rival looms

Encouraging early sales data for oral Wegovy has buoyed Novo Nordisk, as Lilly waits for an FDA decision on its rival orforglipron, now due in Q2.

News

Sanofi linked to takeover bid for Ocular Therapeutix

Sanofi is reported to be preparing a move to take control of US biotech Ocular Therapeutix, after an initial bid was rejected last year.

News

Trump's affordability plan arrives, built around MFN pricing

Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that.

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

News

Oxford BioMedica confirms private equity takeover talks

Oxford BioMedica confirmed this morning that it has received an unsolicited approach from private equity group EQT about a possible takeover.

'Skinny' generic Vascepa label case reaches US Supreme Court

Wegovy pill shows strong early uptake, as rival looms

Sanofi linked to takeover bid for Ocular Therapeutix

Trump's affordability plan arrives, built around MFN pricing

Novartis issues a life sciences warning in a 'G-Zero' world

Oxford BioMedica confirms private equity takeover talks

Trial miss doesn't dent Biogen's faith in Alzheimer's drug

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks